Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-11-19 BESHAR LUKE M Director Exercise or conversion · Stock Option (Right to Buy) −2,604 9,896
2018-11-19 BESHAR LUKE M Director Exercise or conversion · Stock Option (Right to Buy) −6,250 6,250
2018-11-19 BESHAR LUKE M Director Exercise or conversion · Stock Option (Right to Buy) −3,262 9,238
2018-11-19 Yoo Stephen Chief Medical Officer Exercise or conversion +20,414 $0.85 $17K 20,414
2018-11-19 Yoo Stephen Chief Medical Officer Sale −2,761 $57.08 $158K 17,653
2018-11-19 Yoo Stephen Chief Medical Officer Sale −2,300 $58.37 $134K 15,353
2018-11-19 Yoo Stephen Chief Medical Officer Sale −9,092 $59.61 $542K 6,261
2018-11-19 Yoo Stephen Chief Medical Officer Sale −4,361 $60.25 $263K 1,900
2018-11-19 Yoo Stephen Chief Medical Officer Sale −800 $61.55 $49K 1,100
2018-11-19 Yoo Stephen Chief Medical Officer Sale −1,100 $63.21 $70K 0
2018-11-19 Yoo Stephen Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −20,414 61,244
2018-11-16 Simpson Curran SVP, Technical Operations Exercise or conversion +32,882 $22.00 $723K 72,382
2018-11-16 Simpson Curran SVP, Technical Operations Sale −4,000 $61.91 $248K 68,382
2018-11-16 Simpson Curran SVP, Technical Operations Sale −6,883 $62.79 $432K 61,499
2018-11-16 Simpson Curran SVP, Technical Operations Sale −6,505 $63.64 $414K 54,994
2018-11-16 Simpson Curran SVP, Technical Operations Sale −15,494 $64.71 $1.0M 39,500
2018-11-16 Simpson Curran SVP, Technical Operations Exercise or conversion · Stock Option (Right to Buy) −32,882 76,101
2018-11-15 Vasista Vittal Chief Financial Officer Sale −2,170 $58.46 $127K 135,113
2018-11-15 Vasista Vittal Chief Financial Officer Sale −1,900 $59.06 $112K 133,213
2018-11-15 Vasista Vittal Chief Financial Officer Sale −588 $60.40 $36K 132,625

Page 34 of 43 · 852 trades